Novo Nordisk Pharmaceuticals, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Novo Nordisk Pharmaceuticals, Inc. makes
Novo Nordisk Pharmaceuticals, Inc. manufactures insulin delivery devices, including the NovoPen 1.5 and the NovoLinPen Dial-a-Dose insulin delivery device.
These devices are classified as Class II medical devices and are listed in the FDA 510(k) registry; the company is based in the United States.
Catalogue
Novopen 1.5 Ref K942159
Regimes: 510(k) Registry: 510(k)Novofine 31 Disposable Needle Ref K002403
Regimes: 510(k) Registry: 510(k)Novolinpen Dial-A-Dose Insulin Delivery Device Ref K921908
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Novo Nordisk Pharmaceuticals, Inc. have in the registry?
The registry currently lists 3 devices for Novo Nordisk Pharmaceuticals, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Novo Nordisk Pharmaceuticals, Inc.'s devices?
Among its 3 most recently registered devices, Novo Nordisk Pharmaceuticals, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Novo Nordisk Pharmaceuticals, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Novo Nordisk Pharmaceuticals, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Novo Nordisk Pharmaceuticals, Inc. in the registry?
The most recently registered devices listed for Novo Nordisk Pharmaceuticals, Inc. include NOVOPEN 1.5, NOVOFINE 31 DISPOSABLE NEEDLE and NOVOLINPEN DIAL-A-DOSE INSULIN DELIVERY DEVICE.